Search
  • Search


    Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease

    European Commission, DG REGIO - Regional and Urban Policy

    Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease

    1. Competition notice published

      Feb 12, 1:48 PMFebruary 12, 2026 1:48 PM
    2. Supplier selection

      Aug 24, 12:00 AMAugust 24, 2026 12:00 AM
    3. Contract signed

      Sep 15, 12:00 AMSeptember 15, 2026 12:00 AM
    4. Result notice published

      Sep 29, 12:02 PMSeptember 29, 2026 12:02 PM

    Brief

    Belgium: Tenders/European Commission, DG REGIO - Regional and Urban Policy/Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease

    Awarded

    The competition has ended and a winner has been selected.

    Brief

    The European Commission, DG CNECT - Communications Networks, Content and Technology, has entered into an agreement with Huvepharma EOOD for the purchase, storage, and delivery of an estimated maximum of 2,640,000 doses of live attenuated homologous vaccine against Lumpy Skin Disease. The contract has a duration of 4 years and an estimated total value of 2,385,950 EUR. The services include an initial purchase of 528,000 doses and up to four replenishments of 528,000 doses each, storage of an initial stock of 528,000 doses readily available for delivery, timely delivery of all doses to specified destinations, storage of any remaining vaccines until the end of their shelf life, and proper destruction and disposal of unused vaccines. Five bids were received for this contract.

    Result

    Winner
    Huvepharma EOOD
    Number of bids
    5
    Contract value
    €2,385,950

    About the bid

      REASON FOR PURCHASING The Commission has to maintain an estimated stock of at least 528.000 doses of live attenuated Lumpy Skin Disease (LSD) vaccine in storage in order to make it rapidly available in case it is needed. In addition, this stock of 528.000 doses of live attenuated vaccine should be replaced quickly, within 4 weeks, when depleted, in order to maintain the Union’s capability to respond to an emergency. PROCUREMENT DESCRIPTION The purpose of the contract is: • The purchase of an estimated maximum 2.640.000 doses of live attenuated homologous vaccine against LSD. This will be executed with one initial purchase of 528.000 and up to four (4) replenishments, of 528.000 doses each, upon request from the Commission. • The storage of an initial stock of 528.000 doses, readily available for delivery to any of the destinations listed in the technical specifications, that can be replaced, if depleted, partially or totally, up to 4 times until the end of the contract, upon request from the Commission. • The timely delivery of maximum 2.640.000 doses divided in as many consignments as needed to any of the destinations listed in the technical specifications • The storage of any vaccines in stock at the end of the contract for the remainder of their shelf life • The proper destruction and disposal of any unused vaccine at the end of its self life.

      Contact phone
      +32 2 299 11 11
      Contact email
      sante-procurement@ec.europa.eu
      Address
      CSM1, rue Père de Deken 23, B-1040 Brussels

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

    • Description

      Please consult the procurement documents.

    • Description

      Please consult the procurement documents.

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    European Commission, DG REGIO - Regional and Urban Policy
    Title
    Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease
    Type
    ResultPrequalification
    Main code
    33651690Vaccines for veterinary medicine
    Supplemental codes

    No supplemental codes from buyer…

    Estimated value
    €3,200,000.00
    Duration
    48 months

    Active similar competitions

    • Istituto Zooprofilattico Sperimentale della Sardegna

      Fornitura di 400.000 dosi di vaccini veterinari per la profilassi della Lumpy Skin Disease - LSD

      L'Istituto Zooprofilattico Sperimentale della Sardegna necessita della fornitura di 400.000 dosi di vaccini veterinari per la profilassi della dermatite nodulare contagiosa dei bovini (Lumpy Skin Disease - LSD) a Sassari, per un valore massimo totale di 480.000 EUR e una durata di 60 giorni. Huvepharma ha un contratto simile oggi. Il criterio di aggiudicazione è il prezzo.

      CompetitionOct 21, 2026
      Nov 23, 2026(25 days)
      €480,000
    • Ministerie van Economische Zaken

      Engroshandel med medisinske og husholdningsvarer

      Vaccinatiematerialen t.b.v. herkauwers en varkens

      Het Ministerie van Economische Zaken heeft vaccinatiematerialen nodig voor herkauwers en varkens in geval van uitbraken van bestrijdingsplichtige dierziekten, middels een raamovereenkomst van 4 jaar met een maximale totale waarde van 125.793 EUR. De opdracht omvat het beschikbaar stellen van deze materialen. De gunningscriteria zijn kwaliteit (plan van aanpak 35%, opschalen aantallen 15%) en prijs (50%).

      CompetitionOct 15, 2026
      Dec 7, 2026(39 days)
      €125,793
    • Organismo Autónomo Madrid Salud

      Farmasøytisk engroshandel

      Suministro de vacunas con destino al Servicio de Farmacia de Madrid Salud para su dispensación al Centro de Salud Internacional perteneciente al Organismo Autónomo Madrid Salud (8 lotes).

      El Organismo Autónomo Madrid Salud está planificando la adquisición de vacunas para el Servicio de Farmacia de Madrid Salud, destinadas a su dispensación al Centro de Salud Internacional. El contrato tiene una duración de 1 año y un valor máximo estimado de 1.142.490 EUR.

      PlanningJul 3, 2026€1,142,490